PharmaEssentia Corporation (LUX:261280523)

Accolade Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22,034	21,051	19,666	10,304	3,454	3,200
Short-Term Investments	-	-	-	-	-	12
Cash & Short-Term Investments	22,034	21,051	19,666	10,304	3,454	3,212
Cash Growth	14.81%	7.04%	90.86%	198.34%	7.51%	130.17%
Accounts Receivable	2,907	2,624	1,312	798.87	466.04	450.6
Other Receivables	211.43	208.01	236.08	41.22	27.17	2.74
Receivables	3,118	2,832	1,548	840.09	493.22	453.34
Inventory	1,398	1,287	1,459	1,102	861.38	394.85
Prepaid Expenses	272.14	163.58	151.92	55.64	49.02	43.95
Other Current Assets	76.42	83.63	71.18	1,074	69.41	42.91
Total Current Assets	26,899	25,417	22,896	13,375	4,927	4,147
Property, Plant & Equipment	3,605	3,361	2,733	1,018	764.93	891.66
Long-Term Investments	639.7	542.44	163.92	43.24	39.22	95.23
Other Intangible Assets	269.58	272.72	267.91	236.88	246.25	220.65
Long-Term Deferred Tax Assets	1,193	1,120	958.46	483.42	-	-
Other Long-Term Assets	417.57	347.95	249.72	176.38	221.13	176.22
Total Assets	33,024	31,062	27,269	15,333	6,198	5,531
Accounts Payable	188.65	126.47	128.88	230.96	176.38	177.07
Accrued Expenses	955.39	1,106	970.52	667.45	405.5	275.37
Short-Term Debt	-	-	21	993.88	20	50
Current Portion of Long-Term Debt	10.3	11.9	12.36	12.14	12.05	6.5
Current Portion of Leases	205.59	180.56	211.85	77.76	78.59	90.27
Current Income Taxes Payable	249.74	-	0.99	-	-	-
Current Unearned Revenue	-	0.23	-	-	-	-
Other Current Liabilities	1,357	1,132	806.49	568.16	719.44	487.5
Total Current Liabilities	2,967	2,557	2,152	2,550	1,412	1,087
Long-Term Debt	49.32	50.81	62.71	74.98	87.09	99.2
Long-Term Leases	719.74	722.16	892.29	410.05	338.51	400.76
Long-Term Deferred Tax Liabilities	78.6	81.32	105.96	8.22	-	-
Other Long-Term Liabilities	77.1	170.21	97.91	143.64	106.3	20.79
Total Liabilities	3,900	3,593	3,321	3,191	1,948	1,611
Common Stock	3,419	3,418	3,403	3,025	2,769	2,634
Additional Paid-In Capital	23,568	23,547	24,092	13,421	4,697	3,727
Retained Earnings	4,237	2,974	-631.19	-4,186	-2,811	-2,144
Treasury Stock	-2,805	-2,805	-2,805	-87.5	-344.74	-257.24
Comprehensive Income & Other	703.99	335.89	-110.37	-31.54	-60.15	-40.44
Shareholders' Equity	29,123	27,469	23,948	12,141	4,250	3,920
Total Liabilities & Equity	33,024	31,062	27,269	15,333	6,198	5,531
Total Debt	984.94	965.43	1,200	1,569	536.24	646.73
Net Cash (Debt)	21,049	20,086	18,466	8,735	2,917	2,566
Net Cash Growth	16.56%	8.77%	111.40%	199.41%	13.71%	164.17%
Net Cash Per Share	63.00	60.13	57.26	30.73	11.21	10.59
Filing Date Shares Outstanding	333.04	332.89	331.36	301.55	273.06	260.48
Total Common Shares Outstanding	333.04	332.89	331.36	301.55	273.06	260.48
Working Capital	23,932	22,860	20,744	10,825	3,515	3,061
Book Value Per Share	87.45	82.52	72.27	40.26	15.57	15.05
Tangible Book Value	28,853	27,196	23,680	11,904	4,004	3,699
Tangible Book Value Per Share	86.64	81.70	71.46	39.48	14.66	14.20
Land	58.24	58.24	58.24	58.24	58.24	58.24
Buildings	69.82	70.86	70.63	70.61	70.52	70.54
Machinery	804.33	811.38	723.26	534.93	486.58	442.21
Construction In Progress	2,230	2,011	1,188	234.56	36.49	42.56
Leasehold Improvements	466.2	429.87	426.29	371.12	341.61	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.